-
1by Nobuaki Egashira, Shingo Hirakawa, Takehiro Kawashiri, Takahisa Yano, Hiroaki Ikesue, Ryozo Oishi“... and chronic peripheral neuropathies. Mexiletine, an orally available Na+-channel blocker, has widely been used...”
Published 2010-01-01
Get full text
Article